ECG-based risk factors for adverse cardiopulmonary events and treatment outcomes in COPD
These findings suggest the potential clinical relevance of CIIS and P pulmonale as risk indicators for adverse cardiopulmonary events in COPD.
Authors
- R. Chad Wade (ORCID: https://orcid.org/0000-0001-7771-9855)
- Gerard J. Criner (ORCID: https://orcid.org/0000-0003-1267-3483)
- Robert A. Wise (ORCID: https://orcid.org/0000-0002-8353-2349)
- Ravi Kalhan (ORCID: https://orcid.org/0000-0003-2443-0876)
- David Halpin (ORCID: https://orcid.org/0000-0003-2009-4406)
- Lee Tombs
- Mark T. Dransfield (ORCID: https://orcid.org/0000-0002-9207-1820)
- David A. Lipson (ORCID: https://orcid.org/0000-0001-6732-4593)
- Fernando J. Martinez
- Dave Singh (ORCID: https://orcid.org/0000-0001-8918-7075)
- MeiLan K. Han
Institutions
- Northwestern University (US)
- Johns Hopkins University (US)
- Cornell University (US)
- University of Exeter (GB)
- University of Michigan (US)
- Manchester Academic Health Science Centre (GB)
- Johns Hopkins Medicine (US)
- University of Alabama at Birmingham (US)
- Manchester University NHS Foundation Trust (GB)
- GlaxoSmithKline (United States) (US)
- Weill Cornell Medicine (US)
- University of Baltimore (US)
- University of Pennsylvania (US)
- Temple University (US)
Publication Details
- Journal
- European Respiratory Journal
- Published
- 2024-10-28
- DOI
- https://doi.org/10.1183/13993003.00171-2024
- Citations
- 7
- Primary Topic
- Chronic Obstructive Pulmonary Disease (COPD) Research
- Type
- article
- Field-Weighted Citation Impact
- 2.93
Funders
- GlaxoSmithKline
- National Institute for Health and Care Research
- Manchester Biomedical Research Centre